During the last session, Eterna Therapeutics Inc (NASDAQ:ERNA)’s traded shares were 12.56 million, with the beta value of the company hitting 4.37. At the end of the trading day, the stock’s price was $0.64, reflecting an intraday gain of 35.44% or $0.17. The 52-week high for the ERNA share is $2.62, that puts it down -309.38 from that peak though still a striking 65.62% gain since the share price plummeted to a 52-week low of $0.22. The company’s market capitalization is $32.63M, and the average intraday trading volume over the past 10 days was 61.72 million shares, and the average trade volume was 10.79 million shares over the past three months.
Eterna Therapeutics Inc (NASDAQ:ERNA) trade information
Eterna Therapeutics Inc (ERNA) registered a 35.44% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 35.44% in intraday trading to $0.64, hitting a weekly high. The stock’s 5-day price performance is 38.67%, and it has moved by 135.22% in 30 days. Based on these gigs, the overall price performance for the year is -54.31%. The short interest in Eterna Therapeutics Inc (NASDAQ:ERNA) is 44458.0 shares and it means that shorts have 1.07 day(s) to cover.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 0.06%.
ERNA Dividends
Eterna Therapeutics Inc is due to release its next quarterly earnings in February. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Eterna Therapeutics Inc (NASDAQ:ERNA)’s Major holders
Eterna Therapeutics Inc insiders own 336.35% of total outstanding shares while institutional holders control 11.00%, with the float percentage being -4.65%.
Also, the Mutual Funds coming in first place with the largest holdings of Eterna Therapeutics Inc (ERNA) shares are Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund . Data provided on Sep 30, 2024 indicates that Vanguard Extended Market Index Fund owns about 26.1 shares. This amounts to just over 0.05 percent of the company’s overall shares, with a $16575.0 market value. The same data shows that the other fund manager holds slightly less at 13.1, or about 0.03% of the stock, which is worth about $8317.0.
